Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Myelosuppression by sunitinib is flt-3 genotype dependent.
van Erp NP, Mathijssen RH, van der Veldt AA, Haanen JB, Reyners AK, Eechoute K, Boven E, Wessels JA, Guchelaar HJ, Gelderblom H. van Erp NP, et al. Among authors: van der veldt aa. Br J Cancer. 2010 Aug 24;103(5):757-8. doi: 10.1038/sj.bjc.6605813. Epub 2010 Aug 3. Br J Cancer. 2010. PMID: 20683446 Free PMC article. No abstract available.
Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer.
van der Veldt AA, Boven E, Helgason HH, van Wouwe M, Berkhof J, de Gast G, Mallo H, Tillier CN, van den Eertwegh AJ, Haanen JB. van der Veldt AA, et al. Among authors: van wouwe m, van den eertwegh aj. Br J Cancer. 2008 Jul 22;99(2):259-65. doi: 10.1038/sj.bjc.6604456. Epub 2008 Jul 1. Br J Cancer. 2008. PMID: 18594533 Free PMC article. Clinical Trial.
Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival.
van Cruijsen H, van der Veldt AA, Vroling L, Oosterhoff D, Broxterman HJ, Scheper RJ, Giaccone G, Haanen JB, van den Eertwegh AJ, Boven E, Hoekman K, de Gruijl TD. van Cruijsen H, et al. Among authors: van den eertwegh aj, van der veldt aa. Clin Cancer Res. 2008 Sep 15;14(18):5884-92. doi: 10.1158/1078-0432.CCR-08-0656. Clin Cancer Res. 2008. PMID: 18794101
Sunitinib-induced hemoglobin changes are related to the dosing schedule.
van der Veldt AA, Boven E, Vroling L, Broxterman HJ, van den Eertwegh AJ, Haanen JG. van der Veldt AA, et al. Among authors: van den eertwegh aj. J Clin Oncol. 2009 Mar 10;27(8):1339-40; author reply 1340-2. doi: 10.1200/JCO.2008.20.6151. Epub 2009 Feb 2. J Clin Oncol. 2009. PMID: 19188672 No abstract available.
Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib.
Vroling L, van der Veldt AA, de Haas RR, Haanen JB, Schuurhuis GJ, Kuik DJ, van Cruijsen H, Verheul HM, van den Eertwegh AJ, Hoekman K, Boven E, van Hinsbergh VW, Broxterman HJ. Vroling L, et al. Among authors: van cruijsen h, van den eertwegh aj, van hinsbergh vw, van der veldt aa. Angiogenesis. 2009;12(1):69-79. doi: 10.1007/s10456-009-9133-9. Epub 2009 Feb 11. Angiogenesis. 2009. PMID: 19212818 Free article.
199 results